Literature DB >> 8944235

Impact of an infection consultation service for bacteraemia on clinical management and use of resources.

D Nathwani1, P Davey, A J France, G Phillips, G Orange, D Parratt.   

Abstract

Since 1993, the infection consultation service for bacteraemia has seen 310 patients in the Medical and Surgical Directorates at Ninewells Hospital and Kings Cross Hospital. A random sample of 100 was audited. Case-notes were incomplete for five patients, leaving 95 fully-audited patients. Clinical outcome measures were death from infection, and readmission within 2 weeks of discharge. Initial treatment was inconsistent with antibiotic policy in 46 patients (48%). Antibiotic treatment was changed in 37 (80%) of these patients: increased in intensity in 19 (41%) and decreased in 18 (39%). Changes were also made in 30 (61%) of the 49 patients whose initial treatment was consistent with sepsis policy-increased in seven (14%) and decreased in 23 (47%). Median daily antibiotic costs were lowered in patients whose initial treatment was consistent with sepsis policy (pounds 10.10 vs. pounds 7.28, p = 0.0274). However, in the other patients, savings were balanced by increases (p = 0.7696). Consultation required one consultant session per week (3.5 h) and the audit required an additional 16 consultant sessions. Seven patients died, but only one death was directly related to infection. Six patients were readmitted to hospital within 2 weeks, in three due to recurrence of infection. Changes to treatment were recommended in the majority of patients, regardless of whether initial treatment complied with the sepsis policy. The service primarily redistributed resources rather than reducing costs. A fully audited service requires considerable consultant time, but we believe such time is well spent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944235     DOI: 10.1093/qjmed/89.10.789

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  8 in total

1.  Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998-2008): diverse and impactful.

Authors:  G Pongas; G Hamilos; K V Rolston; Dimitrios P Kontoyiannis
Journal:  Support Care Cancer       Date:  2010-12-30       Impact factor: 3.603

2.  Improving early management of bloodstream infection: a quality improvement project.

Authors:  Jane Minton; James Clayton; Jonathan Sandoe; Hugh Mc Gann; Mark Wilcox
Journal:  BMJ       Date:  2008-02-23

Review 3.  [The value of clinical infectology].

Authors:  M Battegay; U Flückiger
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

Review 4.  Critical Care Medicine and Infectious Diseases: An Emerging Combined Subspecialty in the United States.

Authors:  Sameer S Kadri; Chanu Rhee; Gregory S Fortna; Naomi P O'Grady
Journal:  Clin Infect Dis       Date:  2015-05-05       Impact factor: 9.079

5.  The value of specialist care-infectious disease specialist referrals-why and for whom? A retrospective cohort study in a French tertiary hospital.

Authors:  M Sasikumar; S Boyer; A Remacle-Bonnet; B Ventelou; P Brouqui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-17       Impact factor: 3.267

6.  Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.

Authors:  Alexa A Pragman; Michael A Kuskowski; James M Abraham; Gregory A Filice
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2012-07-01

7.  Effects of type and level of training on variation in physician knowledge in the use and acquisition of blood cultures: a cross sectional survey.

Authors:  Jorge P Parada; David N Schwartz; Gordon D Schiff; Kevin B Weiss
Journal:  BMC Infect Dis       Date:  2005-09-15       Impact factor: 3.090

8.  Improved Sepsis Alert With a Telephone Call From the Clinical Microbiology Laboratory: A Clinical Trial.

Authors:  Eleonora Bunsow; Marcela González-Del Vecchio; Carlos Sanchez; Patricia Muñoz; Almudena Burillo; Emilio Bouza
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.